期刊文献+

LSD1和KDM5家族在卵巢癌细胞中的表达及LSD1对细胞增殖迁移的影响 被引量:4

The expression of LSD1 and KDM5 and the effects of LSD1 on proliferation and migration in ovarian cancer cells
下载PDF
导出
摘要 目的:研究赖氨酸特异去甲基化酶1(LSD1)和赖氨酸去甲基化酶5家族(KDM5家族成员)在人卵巢癌细胞中的表达,分析LSD1对细胞增殖迁移的影响。方法:在3种卵巢癌细胞株中,分别用RT-PCR检测LSD1、KDM5A、KDM5B、KDM5C、KDM5D的mRNA的表达,蛋白质印迹法检测前4种酶的表达;在人正常卵巢上皮细胞和癌细胞株中,采用蛋白质印迹法检测LSD1的表达;用MTT法检测LSD1对卵巢癌细胞株增殖的影响;应用划痕试验检测LSD1对卵巢癌细胞株迁移的影响。结果:在3种人卵巢癌细胞的上述5种酶中,LSD1表达水平最高(P<0.01),KDM5家族成员在不同细胞系中差异表达。LSD1抑制剂反苯环丙胺处理卵巢癌细胞后,用MTT法发现抑制LSD1能显著降低癌细胞增殖(P<0.05),刮痕实验发现该药物可显著抑制卵巢癌细胞的迁移(P<0.05)。结论:LSD1在卵巢癌中高表达,KDM5家族差异化表达;LSD1与卵巢癌细胞系的增殖和迁移能力密切相关。 Objective: To investigate the expression of lysine-specific demethylase 1( LSD1) and lysine demethylase 5( KDM5),as well as the role of LSD1 on proliferation and migration within human ovarian cancer cells. Methods: Relative mRNA and protein levels of LSD1,KDM5 A,KDM5B,KDM5 C,KDM5D were detected respectively by real-time quantitative and Western blot in SKOV-3,HO8910,3AO cells. The expressions of LSD1 were comparatively analyzed between a human ovarian epithelial cell line and three ovarian cancer cell lines by Western blot. In addition,the effects of LSD1 on proliferation and migration were determinted by MTT and woundhealing assay respectively. Results: The expression of LSD1 was highest( P〈0. 01),and the expression of KDM5 members was different in these ovarian cancer cells. Tranylcypromine, the inhibitor of LSD1, significantly decreased the proliferation and migration( P〈0. 05). Conclusion: LSD1 expresse at high level and the member of KDM5 family expresse at differentiated level within 3 ovarian cancer cell lines,and LSD1 is significantly correlated with the proliferation and migration within these 3 ovarian cancer cell lines.
出处 《东南大学学报(医学版)》 CAS 北大核心 2016年第3期350-354,共5页 Journal of Southeast University(Medical Science Edition)
基金 国家自然科学基金资助项目(61227803 81170573) 南京农业大学青年基金资助项目(060J2063)
关键词 赖氨酸特异去甲基化酶 卵巢癌 细胞增殖 细胞迁移 lysine-specific demethylase 1 ovarian cancer cell proliferation cell migration
  • 相关文献

参考文献21

  • 1MCGRATH J,TROJER P.Targeting histone lysine methylation in cancer[J].Pharmacol Ther,2015,150:1-22. 被引量:1
  • 2VARIER R A,TIMMERS H T.Histone lysine methylation and demethylation pathways in cancer[J].Biochim Biophys Acta,2011,1815(1):75-89. 被引量:1
  • 3THINNES C C,ENGLAND K S,KAWAMURA A,et al.Targeting histone lysine demethylases-progress,challenges,and the future[J].Biochim Biophys Acta,2014,1839(12):1416-1432. 被引量:1
  • 4LAN F,NOTTKE A C,SHI Y,Mechanisms involved in the regulation of histone lysine demethylases[J].Curr Opin Cell Biol,2008,20(3):316-325. 被引量:1
  • 5ROTILI D,MAI A.Targeting histone demethylases:a new avenue for the fight against cancer[J].Genes Cancer,2011,2(6):663-679. 被引量:1
  • 6SHAO G,WANG J,LI Y,et al.Lysine-specific demethylase 1 mediates epidermal growth factor signaling to promote cell migration in ovarian cancer cells[J].Sci Rep,2015,5:15344. 被引量:1
  • 7ZHENG Y C,MA J,WANG Z,et al.A systematic review of histone lysine-specific demethylase 1 and its inhibitors[J].Med Res Rev,2015,35(5):1032-1071. 被引量:1
  • 8LYNCH J T,HARRIS W J,SOMERVAILLE T C.LSD1 inhibition:a therapeutic strategy in cancer?[J].Expert Opin Ther Targets,2012,16(12):1239-1249. 被引量:1
  • 9WANG Q,WEI J,SU P,et al.Histone demethylase JARID1C promotes breast cancer metastasis cells via down regulating BRMS1 expression[J].Biochem Biophys Res Commun,2015,464(2):659-666. 被引量:1
  • 10LI N,DHAR S S,CHEN T Y,et al.JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis[J].Cancer Res,2016,76(4):831-843. 被引量:1

二级参考文献14

  • 1SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2012[J]. CA Cancer J Clin,2012,62( 1 ) :10-29. 被引量:1
  • 2OLIVE V,BENNETF M J,WALKER J C,et al. miR- 19 is a key oncogenie component of mir-17-92[J]. Genes Dev,2009, 23 (24) :2839-2849. 被引量:1
  • 3JI M, RAO E, RAMACHANDRAREDDY H, et al. The miR- 17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies[ J]. Am J Pathol,2011,179(4) :1645- 1656. 被引量:1
  • 4GARZON R,CALIN G A,CROCE C M. MicroRNAs in cancer [ J-. Annu Rev Med,2009,60 : 167-179. 被引量:1
  • 5MENDELL J T. miRiad roles for the miR-17-92 cluster in development and disease [J]. Cell ,2008,133 ( 2 ) :217-222. 被引量:1
  • 6DIOSDADO B,van de WIEL M A,TERHAAR-SIVE-DROSTE J S, et al. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression[J]. Br J Cancer,2009,101 (4) :707-714. 被引量:1
  • 7HAYASHITA Y, OSADA H,TATEMATSU Y, et al. A polycis- tronic microRNA cluster, miR-17- 92 , is overexpressed in hu- man lung cancers and enhances cell proliferation [ J ]. Cancer Res ,2005,65 (21) :9628-9632. 被引量:1
  • 8YU G, TANG J, TIAN M, et al. Prognostic values of the miR- 17-92 cluster and its paralogs in colon cancer[J]. J Surg On- col ,2012,106 (3) :232-237. 被引量:1
  • 9WANG M,GU H,WANG S,et al. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer [ J ]. Mol Med Rep,2012,5 (6) :1514-1520. 被引量:1
  • 10XU X M, WANG X B, CHEN M M, et al. MicroRNA-19a and-19b regulate cervical carcinoma cell proliferation and in- vasion by targeting CUL5 [ J ]. Cancer Lett, 2012,322 ( 2 ) : 148-158. 被引量:1

共引文献5

同被引文献26

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部